NY State Approves Quest Diagnostics Fragile X Syndrome Test
XSense, Fragile X with Reflex, from Quest Diagnostics Inc has been approved by New York States Department of Health.
Read MoreSearch Results for: genetic testing
Shifting Standards in Respiratory Virus Diagnostics
Molecular diagnostics are replacing culture as the gold standard but continue to share the stage with conventional methods.
Read MoreSeegene Announces SeePrep and SeeCycler Systems
Seegene announced SeePrep and SeeCycler, new clinical instrumentation optimized for Seegene’s multiplex real-time detection tests.
Read MoreNew Report Examines Future of Molecular Diagnostics
MarketResearch.com has announced the addition of Business Insights’ new report “The Future of Molecular Diagnostics: Innovative technologies driving market opportunities in personalized medicine.”
Read MorePsoriasisDX Genetic Test for Psoriatic Arthritis Now Available In Europe
Molecular dermatology research and development innovator DermaGenoma Inc announced that the PsoriasisDX Genetic Test for Psoriatic Arthritis (PsA) is now available as a CE Marked product under the European In Vitro Diagnostic Directive.
Read More